Characteristics | Hepatic function | ||||
---|---|---|---|---|---|
Normal (n = 11) | Mild impairment (n = 17) | Moderate impairment (n = 14) | Severe impairment (n = 4) | Total (N = 46) | |
Sex, n (%) | |||||
Male | 9 (82) | 9 (53) | 9 (64) | 1 (25) | 28 (61) |
Race, n (%) | |||||
Black | 0 (0) | 1 (5.9) | 1 (7) | 0 (0) | 2 (4) |
White | 11 (100) | 13 (76.5) | 13 (93) | 4 (100) | 41 (89) |
Not reported | 0 (0) | 3 (17.6) | 0 (0) | 0 (0) | 3 (7) |
Age, years | |||||
Median | 69.0 | 59.0 | 62.5 | 54.5 | 63.5 |
Range, min–max | 55–78 | 37–74 | 47–70 | 45–71 | 37–78 |
≥65 years, n (%) | 8 (72.7) | 5 (29.4) | 6 (42.9) | 1 (25.0) | 20 (43.5) |
ECOG performance status, n (%) | |||||
0 or 1 | 11 (100) | 13 (76) | 12 (86) | 4 (100) | 40 (87) |
2 | 0 (0) | 4 (24) | 2 (14) | 0 (0) | 6 (13) |
Time from initial diagnosis to informed consent, years | |||||
Median | 3.75 | 2.95 | 2.34 | 2.78 | 2.82 |
Min, max | 0.8, 9.4 | 0.9, 16.4 | 0.7, 7.8 | 1.3, 4.0 | 0.7, 16.4 |
Current disease stage, n (%) | |||||
3 | 0 (0) | 0 (0) | 3 (21) | 1 (25) | 4 (9) |
4 | 8 (73) | 16 (94) | 10 (71) | 3 (75) | 37 (80) |
Unknown | 1 (9) | 1 (6) | 1 (7) | 0 (0) | 3 (7) |
Missing | 2 (18) | 0 (0) | 0 (0) | 0 (0) | 2 (4) |